WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005037785) DERIVATIVES OF N-[PHENYL(PYRROLIDINE-2-YL)METHYL]BENZAMIDE AND N-[(AZEPAN-2-YL)PHENYLMETHYL]BENZAMIDE, PREPARATION METHOD THEREOF AND APPLICATION OF SAME IN THERAPEUTICS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/037785    International Application No.:    PCT/FR2004/002644
Publication Date: 28.04.2005 International Filing Date: 15.10.2004
IPC:
C07D 207/09 (2006.01), C07D 223/04 (2006.01)
Applicants: SANOFI-AVENTIS [FR/FR]; 174, avenue de France, F-75013 Paris (FR) (For All Designated States Except US).
DARGAZANLI, Gihad [FR/FR]; (FR) (For US Only).
ESTENNE-BOUHTOU, Geneviève [FR/FR]; (FR) (For US Only).
MEDAISKO, Florence [FR/FR]; (FR) (For US Only).
RAKOTOARISOA, Nathalie [FR/FR]; (FR) (For US Only)
Inventors: DARGAZANLI, Gihad; (FR).
ESTENNE-BOUHTOU, Geneviève; (FR).
MEDAISKO, Florence; (FR).
RAKOTOARISOA, Nathalie; (FR)
Agent: LUDWIG, Jacques; Sanofi-Aventis, 174, avenue de France, F-75013 Paris (FR)
Priority Data:
0312143 17.10.2003 FR
Title (EN) DERIVATIVES OF N-[PHENYL(PYRROLIDINE-2-YL)METHYL]BENZAMIDE AND N-[(AZEPAN-2-YL)PHENYLMETHYL]BENZAMIDE, PREPARATION METHOD THEREOF AND APPLICATION OF SAME IN THERAPEUTICS
(FR) DERIVES DE N-[PHENYL(PYRROLIDIN-2-YL)METHYL]BENZAMIDE, ET N-[AZEPAN-2-YL) PHENYLMETHYL]BENZAMIDE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
Abstract: front page image
(EN)The invention relates to compounds having general formula (I), wherein: n represents the number 1 or 3; R1 represents either H or a cycloalkyl, cycloalkylalkyl, phenylalkyl, alkenyl, alkynyl group; X represents either H or one or more substituents selected from among halogen atoms and the trifluoromethyl, alkyl and alkoxy groups; and R2 represents H, or one or more substituents selected from among the halogen atoms and the trifluoromethyl, alkyl, alkoxy, cycloalkyl, phenyl, cyano, acetyl, benzoyl, S-alkyl, alkyl-sulfonyl, carboxy and alkoxycarbonyl groups, or a group having formula NR3R4, SO2NR3R4 or CONR3R4, in which R3 and R4 each represent H or an alkyl or cycloalkyl group or, together with the nitrogen atom, form a pyrrolidine, piperidine or morpholine ring. The invention also relates to the use of said compounds in therapeutics.
(FR)Composés de formule générale (I), dans laquelle n représente le nombre 1 ou 3, R1 représente soit H, soit un groupe cycloalkyle, cycloalkylalkyle, phénylalkyle, alcényle, alcynyle, X représente soit H soit un ou plusieurs substituants choisis parmi les atomes d'halogènes et les groupes trifluorométhyle, alkyles et alcoxy, R2 représente soit H, soit un ou plusieurs substituants choisis parmi les atomes d'halogènes, et les groupes trifluorométhyle, alkyles, alcoxy, cycloalkyles, phényle, cyano, acétyle, benzoyle, S-alkyles, alkyl-sulfonyles, carboxy et alcoxycarbonyles, soit un groupe de formule NR3R4, SO2NR3R4 ou CONR3R4, dans lesquelles R3 et R4 représentent chacun H ou un groupe alkyle ou cycloalkyle, ou forment, avec l'atome d'azote, un cycle pyrrolidine, pipéridine ou morpholine. Application en thérapeutique.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: French (FR)
Filing Language: French (FR)